Subcutaneous recombinant erythropoietin in the treatment of renal anaemia in CAPD patients.
Macdougall
I C
IC
KRUF Institute of Renal Disease, Royal Infirmary, Cardiff, UK.
Cavill
I
I
Davies
M E
ME
Hutton
R D
RD
Coles
G A
GA
Williams
J D
JD
D000328:Adult; D000368:Aged; D000740:Anemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D001810:Blood Volume / Q000187:drug effects; D004921:Erythropoietin / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D007279:Injections, Subcutaneous; D007501:Iron / Q000097:blood; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory
D006454:Hemoglobins; D004921:Erythropoietin; D007501:Iron